ストックスクリーナーアプリを入手
5.84
0.68%
-0.04
Exicure Inc (XCUR) 最新ニュース
Why Exicure Inc. (2H0) stock attracts HNW investorsJuly 2025 Rallies & Stepwise Entry and Exit Trade Signals - ulpravda.ru
Exicure HiTron sells $3.3m in Exicure shares By Investing.com - Investing.com Australia
Exicure Hitron Sells Over 740K Shares - TradingView — Track All Markets
Exicure HiTron sells $3.3m in Exicure shares - Investing.com
Insider Sale: 10% owner at $XCUR Sells 741,272 Shares - Quiver Quantitative
Why Exicure Inc. stock is rated strong buyMarket Growth Review & Daily Stock Trend Watchlist - ulpravda.ru
Avoiding Lag: Real-Time Signals in (XCUR) Movement - Stock Traders Daily
Bond Watch: Why Exicure Inc 2H0 stock attracts HNW investorsWeekly Loss Report & Low Volatility Stock Suggestions - moha.gov.vn
Aug Highlights: Is Exicure Inc 2H0 stock worth buying before Fed actionWeekly Risk Report & Verified Short-Term Trading Plans - moha.gov.vn
Exicure (XCUR) Stock Soars on Burixafor Phase 2 Data: What December 2025 Investors Need to Know - ts2.tech
Promising Biotech Stocks To Keep An Eye OnDecember 9th - MarketBeat
Buyback Watch: Is Exicure Inc 2H0 stock worth buying before Fed action2025 Key Highlights & Free Fast Gain Swing Trade Alerts - moha.gov.vn
Exicure Regains Nasdaq Compliance as of July 2025 - The Globe and Mail
Trading Action: Why Exicure Inc stock is rated strong buyAnalyst Downgrade & Free High Accuracy Swing Entry Alerts - moha.gov.vn
(XCUR) Risk Channels and Responsive Allocation - Stock Traders Daily
Exicure presents topline data from burixafor combination trial - MSN
Will Exicure Inc. stock benefit from upcoming earnings reportsM&A Rumor & Accurate Intraday Trading Signals - DonanımHaber
Is Exicure Inc. stock ready for breakoutMarket Trend Review & Technical Confirmation Trade Alerts - ulpravda.ru
Exicure stock soars 40% after stem cell drug helps most patients hit phase 2 goal — traders call it 'cheap' at current levels - MSN
Trading the Move, Not the Narrative: (XCUR) Edition - Stock Traders Daily
Argenx, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Exit Recap: Will Exicure Inc stock recover faster than marketSwing Trade & Real-Time Chart Pattern Alerts - moha.gov.vn
Promising Biotech Stocks To Keep An Eye On – December 9th - Defense World
Sangsangin investment sells Exicure (XCUR) shares worth $3.77 million By Investing.com - Investing.com Nigeria
XCUR Insider Trading - Quiver Quantitative
Sangsangin Investment & Securities Sells All Exicure Shares - TradingView — Track All Markets
Shareholder Sangsangin Investment & Securities Co Ltd Sells 433,332 ($3.8M) Of Exicure Inc [XCUR] - TradingView — Track All Markets
Exicure’s Risky Bet On Stem Cell Mobilization Pays Early Dividends - Finimize
Morning Market Movers: ASPC, ENVB, AFJK, JXG See Big Swings - RTTNews
Exicure’s Stunning Rise: What’s Fueling It? - StocksToTrade
Exicure Shares Surge 41% On Promising Phase 2 Data For Multiple Myeloma Drug - Nasdaq
Exicure Stock Soars 40% After Stem Cell Drug Helps Most Patients Hit Phase 2 Goal — Traders Call It ‘Cheap’ At Current Levels - Stocktwits
Exicure Rally Fueled By Rapid Cell-Boosting Results In Blood Cancer Trial - Benzinga
Top Gainers on the US Stock Market Today (December 9, 2025): AFJK, NCPL, XCUR, ALEX and More Surge as Fed Meeting Looms - ts2.tech
Exicure (XCUR) Stock: Biotech Soars on Promising Cancer Drug Data - parameter.io
ASH: Exicure rebounds with phase 2 win, seeing 90% blood cell mobilization in myeloma - Fierce Biotech
Dow Surges Over 100 Points; Campbell's Posts Upbeat Earnings - Benzinga
This BlackRock stock just rocketed 70% - Finbold
Exicure (XCUR) Stock: Biotech Shares Surge 140% on Cancer Drug Breakthrough - Blockonomi
Exicure Inc.: Is It a Bet Worth Taking? - timothysykes.com
Exicure Inc (XCUR) expanding its growth trajectory ahead - setenews.com
Pre Market Movers: XCUR, VOR, MTVA Set The Path - RTTNews
Morning Market Movers: ATMC, XCUR, VOR, ATMV See Big Swings - RTTNews
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
0.90%
大文字化:
|
ボリューム (24 時間):